Page 10 - Iontech News Today

Pfizer and BioNTech Submit for U.S. Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Booster in Children Under 5 Years NEW YORK and... | March 1, 2023

NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) and BioNTech (BNTX) have started a Phase 1/2 trial for their mRNA vaccine candidates against shingles, an infectious disease caused by the reactivation

Bill Gates did a 180-degree turn when he publicly besmirched the mRNA vaccines that only two years before he had described as magic.

POWELL, OH—Deciding to take the rest of the day off to recover, local sedentary man Clay Broderman was reportedly reminded Friday what muscle soreness felt like after receiving his first dose of Pfizer-BioNTech Covid vaccine. “What the hell is happening—what is this strange sensation I’m feeling in my upper arm right…

A panel of scientists and doctors will evaluate progress to tackle the outbreak three years after it first sounded the alarm.

Acquisition accelerates Projectmates growth into international markets and amplifies Hexagon’s commitment to breakthrough construction technology products...

BioNTech says its InstaDeep acquisition will help it expand its use of artificial intelligence in drug discovery and development. The startup specializes in a type of machine learning called reinforcement learning.

Rise in daily vaccine uptake marks sharp increase from 2,000 recorded early last month, with jump beginning when Hong Kong announced Covid policy rollback.

BioNTech and its partner for China, Shanghai Fosun Pharmaceutical, were granted approval for their COVID-19 vaccine that is adapted for the BA.4 and the BA.5 subvariants of Omicron for people aged... | December 24, 2022

As Beijing abandons zero-Covid, foreign jabs and antiviral medicine are key to limiting deaths, according to epidemiologists.